HemaSphere (Jun 2022)

PB2178: OUTCOMES OF REDUCED DOSE TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HODGKIN AND NON-HODGKIN LYMPHOMA: A MONOCENTRIC EXPERIENCE

  • S. Di Folca,
  • V. Marafioti,
  • S. barbato,
  • S. Avilia,
  • F. Grimaldi,
  • A. Severino,
  • M. Picardi,
  • L. Luciano,
  • G. Battipaglia,
  • F. Pane

DOI
https://doi.org/10.1097/01.HS9.0000851540.26904.c2
Journal volume & issue
Vol. 6
pp. 2048 – 2049

Abstract

Read online

No abstracts available.